Related Experiment Video
Updated: May 25, 2026
07:17
Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
Reactive oxygen species in cancer stem cells
Xiaoke Shi1, Yan Zhang, Junheng Zheng
1Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Antioxidants & Redox Signaling
|February 10, 2012
Summary
Reactive oxygen species (ROS) play dual roles in cancer. While elevated endogenous ROS promote cancer, exogenous ROS may selectively kill cancer cells, offering a potential therapeutic strategy against cancer stem cells (CSCs).
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Cancer stem cells (CSCs) are critical drivers of tumor progression, metastasis, and resistance to therapies.
- Intracellular reactive oxygen species (ROS) in CSCs are a key area of ongoing research.
- Understanding ROS in CSCs is vital for developing novel cancer treatments.
Purpose of the Study:
- To explore the multifaceted roles of reactive oxygen species (ROS) in cancer.
- To investigate the implications of ROS in cancer stem cells (CSCs).
- To evaluate the potential of exogenous ROS as a therapeutic strategy against CSCs.
Main Methods:
- Review of current literature on ROS and CSCs.
- Analysis of the redox balance in normal stem cells versus CSCs.
- Comparative study of endogenous and exogenous ROS effects.
Main Results:
- Increased endogenous ROS are implicated in tumorigenesis, metastasis, and treatment resistance.
- Exogenous ROS can disrupt the redox balance and selectively eliminate cancer cells.
- Normal stem cells thrive in low-ROS environments, while CSC roles are less understood.
Conclusions:
- ROS exhibit complex roles in cancer, with potential for therapeutic exploitation.
- Targeting ROS in CSCs presents a promising avenue for cancer therapy.
- Future research should focus on leveraging exogenous ROS to eradicate CSCs.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...